Antipodes Partners’s Lineage Inc LINE Stock Holding History

Antipodes Partners’s Portfolio LINE Stock Details LINE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,729	Closed	-$236K	–	153
2025 Q4	$236K	Buy	+6,729	New	+$249K	﹤0.01%	83

Other funds holding LINE

D1 Capital Partners New York $34.8B AUM 11.34% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DPCM

Darlington Partners Capital Management Greenbrae, California $2.27B AUM 18.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Antipodes Partners's LINE Position: Q1 2026 in Review

Antipodes Partners sold out of Lineage Inc (LINE) in Q1 2026, closing a stake of 6,729 shares — an estimated $236K sold.

Antipodes Partners first reported a position in LINE in Q4 2025 and held it in 1 quarter. The position peaked at $236K in Q4 2025. 309 funds tracked by Wall St. Rank hold LINE as of Q1 2026.

Antipodes Partners reported no remaining Lineage Inc position as of Q1 2026 after selling out during the quarter.
Antipodes Partners sold 6,729 Lineage Inc shares in Q1 2026, an estimated $236K.
Antipodes Partners first reported a position in Lineage Inc in Q4 2025 and held it in 1 quarter.
Antipodes Partners's Lineage Inc position peaked at $236K in Q4 2025.
309 funds tracked by Wall St. Rank held Lineage Inc as of Q1 2026.

Based on Antipodes Partners's 13F filing for Q1 2026, filed 5 May 2026.